comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 06:18:55 - browse：5723

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Today's health inequities arise from racist U.S. history, say experts

hotspot

WSS

Solving academic medical centers' existential crisis

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medical school prerequisites are outdated

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Venture capitalist Bob Kocher on the state of digital health

Medical school prerequisites are outdated

hotspot

comprehensive

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ventyx halts psoriasis drug development after lackluster trial results

ChatGPT in medicine: STAT answers readers' burning questions

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Jerome Adams on the need for new antivirals for Covid

Study suggests Covid rebound is far more common with Paxlovid than without

Sports medicine is finally prioritizing gender equality

Healthy food access boosts outcomes in two studies

In Memoriam: Notable people who died in 2023

Medical school prerequisites are outdated

focus

What health policies could hitch a ride on a spending bill?

What is STAT's opinion section for?

Readout Newsletter: Zepbound, Valneva's vaccine, and more

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Cancer diagnosis changes perspective doctor, former hospital CEO

Criminal prosecution for violating HIPAA: an emerging threat

knowledge

focus

hotspot

Wikipedia